BioNTech | Results Presentation Deck | 40 slides

BioNTech · 2021-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

40
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
This is a standard pharmaceutical regulatory disclosure slide.other
Open slide detailBeat · Attention
04
Includes specific clinical trial adverse reaction percentages and reporting instructions.other
Open slide detailBeat · Attention
05
front_matter
Open slide detailBeat · Attention
06
front_matter
Open slide detailBeat · NeedLoop · Logic Chain
07
The slide uses a hub-and-spoke style diagram to show how integrated capabilities feed into the pipeline.summarize
Open slide detailBeat · NeedLoop · Logic Chain
08
The slide uses a comparison structure to contrast two primary therapeutic areas.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
09
The slide uses a structured layout to categorize updates into three main pillars.summarize
Open slide detailBeat · NeedLoop · Logic Chain
10
transition
Open slide detailBeat · NeedLoop · Logic Chain
11
Slide 11 from a BioNTech presentation.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
12
The slide lists five levers, though the title mentions six.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
13
Includes immunobridging data and efficacy summary across age groups.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
14
Slide 14 from a BioNTech presentation.present_solution
Open slide detailBeat · SatisfactionLoop · Logic Chain
15
Includes two distinct chart types: a dot plot with box-and-whisker elements for neutralization titers and a summary table for vaccine efficacy.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
16
Includes data from Israeli Ministry of Health and US healthcare records.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
17
transition
Open slide detailBeat · SatisfactionLoop · Logic Chain
18
The slide uses a hub-and-spoke diagram to connect a central patient/disease focus to multiple therapeutic modalities.present_framework
Open slide detailBeat · SatisfactionLoop · Logic Chain
19
The slide uses a three-column layout to categorize clinical progress. SITC refers to the Society for Immunotherapy of Cancer conference.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
20
Includes a process flow diagram illustrating the current standard of care and patient outcomes.diagnose_problem
Open slide detailBeat · SatisfactionLoop · Logic Chain
21
summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
22
Includes reference to Nature publication and SITC 2021 presentation.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
23
Includes trial schema (Part 1/2) and summary of patient characteristics, adverse events, and immune responses.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
24
The slide illustrates a dual-component therapy (CAR-T + RNA vaccine) and a multi-part clinical trial design.present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
25
Slide 25 of a BioNTech presentation.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
26
Includes a diagram of the mechanism of action and a process flow for the clinical trial.present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
28
The slide outlines the mechanism of a bispecific antibody and the trial structure (dose escalation followed by expansion cohorts).present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
29
Clinical trial data summary slide.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
30
The slide uses a process flow diagram to describe the study design and three summary boxes for key clinical findings.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
31
transition
Open slide detailBeat · Action
32
The table shows a significant increase in commercial revenues and profit for 2021 compared to 2020.analyze_data
Open slide detailBeat · Action
33
The chart breaks down revenue into four categories, with COVID-19 vaccine revenues being the primary driver.analyze_data
Open slide detailBeat · Action
34
analyze_data
Open slide detailBeat · Action
35
front_matter
Open slide detailBeat · Action
36
The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.illustrate_case
Open slide detailBeat · Action
37
present_solution
Open slide detailBeat · Action
38
The table uses a Gantt-style visualization for clinical trial phases, though all shown candidates are currently in Phase 1/2.analyze_data
Open slide detailBeat · Action
39
summarize
Open slide detailBeat · Action
40
other
Open slide detailBeat · Action